🇺🇸 FDA
Pipeline program

OROS hydromorphone

CR100659

Approved small_molecule completed

Quick answer

OROS hydromorphone for Cancer Pain is a Approved program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen Cilag International NV
Indication
Cancer Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials